Western blot and qRT-PCR analysis confirmed GPS improve NASH by regulating PPARα and Hypoxia-Inducible Factor-1α (HIF-1α) signaling pathways. The gene discussed is HIF1A; the disease is metabolic dysfunction-associated steatohepatitis.